DystoPunk 3D

Price Rationale

Final value is centered near the confidence-weighted appraiser consensus while giving extra caution for liquidity. The strongest hard evidence is the exact SuperRare onchain sale at 40 ETH on 2020-01-23, equal to $6,671.60 at the time, which was a strong early-2020 ETH print versus nearby XCOPY 1/1 sales. The work is a supply-1 January 2020 XCOPY with explicit XCOPY and Coldie collaboration metadata, supporting a premium to the stale 40 ETH sale. However, it has no current ask, no current best bid, no OTC history, no grail flag, no outgoing candidate benchmarks, and no recent exact-token sale. A 60 ETH bid, 90 ETH fair value, and 125 ETH patient ask balance the early-sale strength and cultural/collaboration context against thin current market evidence.

What Caps The Price

A higher valuation would rely too heavily on broader XCOPY appreciation and stronger same-era anchors that have fresher or more canonical demand evidence. DystoPunk 3D is not flagged as a grail, has no live bid or ask, has no OTC sale record, has candidateCount 0, and has not traded since the 40 ETH sale in January 2020. The collaboration is additive but may also trade differently from a pure XCOPY flagship, so pushing toward 150 ETH or more is not supported by the packet.

What Supports The Price

A lower valuation would underweight the unusually strong 40 ETH exact-token sale only six days after mint, especially when many nearby early-2020 XCOPY 1/1 sales were far lower in ETH. It is still a supply-1 SuperRare XCOPY from January 2020 with distinctive XCOPY x Coldie 3D collage context, and the global snapshot includes non-grail XCOPY works with later validations meaningfully above this zone, so treating it as only a stale 40 ETH asset would be too punitive.